4//SEC Filing
TherapeuticsMD, Inc. 4
Accession 0001387131-14-001135
$TXMDCIK 0000025743operating
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:06 PM ET
Size
8.4 KB
Accession
0001387131-14-001135
Insider Transaction Report
Form 4
SEGAL NICHOLAS
Director
Transactions
- Sale
Common Stock
2014-03-26$6.70/sh−30,000$200,913→ 215,485 total - Sale
Common Stock
2014-03-26$6.70/sh−185,298$1,240,959→ 225,809 total(indirect: By Fourth Generation Private Equity Partners)
Holdings
- 146,560(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Fourth Generation Private Equity sold 1,600,000 shares of TherapeuticsMD, Inc. (the "Company") common stock. Mr. Segal owns 11.5811% interest, Partners ("FG"), of which Mr. Segal disclaims beneficial ownership of these securities held by FG except to the extent of his pecuniary interest therein.
- [F2]Represents Mr. Segal's pro rata portion of 1,949,805 shares of the Company's common stock held directly by FG. Mr. Segal disclaims beneficial ownership of securities held by FG except to the extent of his pecuniary interest therein.
- [F3]Represents Mr. Segal's aggregate direct and indirect pro rata portion of 1,600,000 shares of the Company's common stock held by Seavest Capital Ventures, LLC ("Seavest"). Mr. Segal directly holds a 4.995% interest in Seavest and indirectly holds a 4.165% interest in Seavest, through his ownership interest in FG, which owns a 35.964% interest in Seavest. Mr. Segal disclaims beneficial ownership of securities held by Seavest except to the extent of his pecuniary interest therein.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000025743
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:06 PM ET
- Size
- 8.4 KB